Key result
Socioeconomic deprivation is not associated with 1-year mortality or hospitalization in peripartum cardiomyopathy.
Why the study?
Peripartum cardiomyopathy disproportionately affects socioeconomically disadvantaged women, but the prognostic impact of deprivation in contemporary U.S. health systems remains uncertain.
Does socioeconomic deprivation worsen 12-month clinical outcomes in patients with peripartum cardiomyopathy?
Cohort (n=2,596)
Yes
Does socioeconomic deprivation worsen 12-month clinical outcomes in patients with peripartum cardiomyopathy?
Hazard Ratio: 1.03 (95% CI 0.89–1.19)
p-value: p=0.728
In a contemporary U.S. cohort, socioeconomic deprivation was not associated with worse 1-year mortality or hospitalization rates in women with peripartum cardiomyopathy.
BACKGROUND Peripartum cardiomyopathy disproportionately affects women experiencing socioeconomic disadvantage, yet the prognostic impact of deprivation within contemporary U.S. health systems remains uncertain. OBJECTIVE To evaluate whether socioeconomic deprivation independently influences 1-year clinical outcomes in patients with peripartum cardiomyopathy. STUDY DESIGN This retrospective cohort study used the TriNetX U.S. research network (2015-2024) to identify adults with peripartum cardiomyopathy. Socioeconomic deprivation was defined using validated ICD-10/HCPCS social risk codes. Patients were propensity score-matched (1:1) for demographics, comorbidities, medications, and laboratory values. Cox proportional hazards models estimated 12-month outcomes. RESULTS After 1:1 propensity score matching, 1,298 women were included in each cohort, with balanced baseline characteristics. At 12 months, socioeconomic deprivation was not associated with the primary composite outcome of all-cause mortality or hospitalization (HR 1.03; 95% CI 0.89-1.19; P=0.728), nor with either component individually. Socioeconomically deprived women had lower hazards of heart failure events (HR 0.82; 95% CI 0.73-0.93; P=0.001) and arrhythmia (HR 0.83; 95% CI 0.70-0.99; P=0.039). No significant differences were observed in thromboembolic events, new-onset thromboembolism, cardiogenic shock, or procedural outcomes. CONCLUSIONS In this large real-world U.S. cohort, socioeconomic deprivation did not worsen 1-year outcomes in peripartum cardiomyopathy, suggesting that access to high-quality, equitable care may attenuate socioeconomic disparities.
No takes yet. Share an insight, caveat, or question.
Paray et al. (2026) conducted a cohort in Peripartum cardiomyopathy (n=2,596). Socioeconomic deprivation vs. No socioeconomic deprivation was evaluated on Composite outcome of all-cause mortality or hospitalization (HR 1.03, 95% CI 0.89-1.19, p=0.728). Socioeconomic deprivation was not associated with 12-month all-cause mortality or hospitalization in women with peripartum cardiomyopathy (HR 1.03; 95% CI 0.89-1.19; P=0.728).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: